As expected, MEG3 displayed negligible expression in the WT1-mutant AML cell lines (U937) relative to WT1- and TET2-wild-type AML cells (Figure 1c; Supplementary Figure 1B). This evidence concerns the gene MEG3 and acute myeloid leukemia.